Riluzole stimulates BDNF release from human platelets

Detalhes bibliográficos
Autor(a) principal: Turck, Patrick
Data de Publicação: 2015
Outros Autores: Frizzo, Marcos Emilio dos Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/225834
Resumo: Brain-derived neurotrophic factor (BDNF) has several functions in the central nervous system, where it contributes to brain development and its functionality through affecting neuronal survival and activity and also modulating neurotransmitter levels. This neurotrophin is also found in the serum, but its origin and peripheral function remain unknown. Although the source of circulating BDNF is uncertain, it is stored in platelets and can be released through pharmacological treatment. Decreased levels of BDNF in the serum have been related to the pathophysiology of depression, and this relationship is reinforced by the reversal of this condition by treatment with antidepressants. Recently, riluzole has been proposed for the treatment of depression because it has the ability to lower extracellular glutamate levels and increase BDNF expression; and both mechanisms could be associated with its antidepressant action. Considering that riluzole enhances BDNF levels in the serum of patients, we investigated if treatment with this drug could stimulate the release of this neurotrophin from human platelets obtained from healthy subjects. When platelets were incubated with riluzole for 4 h, the basal value of BDNF (92.9 ± 11.1 pg 10−6 platelets) was significantly increased ( < 0.05, = 27). This stimulatory effect was achieved at low concentrations of riluzole (from 10 M) and was not observed when platelets were incubated with the drug for 24 h. The direct action of riluzole evoking BDNF release from human platelets at therapeutic concentrations is important and may contribute to the understanding of its mechanisms of action in the treatment of depression.
id UFRGS-2_ddeb17d9a880bcf34d1bbdeb48e23908
oai_identifier_str oai:www.lume.ufrgs.br:10183/225834
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Turck, PatrickFrizzo, Marcos Emilio dos Santos2021-08-18T04:39:24Z20152314-6133http://hdl.handle.net/10183/225834000968009Brain-derived neurotrophic factor (BDNF) has several functions in the central nervous system, where it contributes to brain development and its functionality through affecting neuronal survival and activity and also modulating neurotransmitter levels. This neurotrophin is also found in the serum, but its origin and peripheral function remain unknown. Although the source of circulating BDNF is uncertain, it is stored in platelets and can be released through pharmacological treatment. Decreased levels of BDNF in the serum have been related to the pathophysiology of depression, and this relationship is reinforced by the reversal of this condition by treatment with antidepressants. Recently, riluzole has been proposed for the treatment of depression because it has the ability to lower extracellular glutamate levels and increase BDNF expression; and both mechanisms could be associated with its antidepressant action. Considering that riluzole enhances BDNF levels in the serum of patients, we investigated if treatment with this drug could stimulate the release of this neurotrophin from human platelets obtained from healthy subjects. When platelets were incubated with riluzole for 4 h, the basal value of BDNF (92.9 ± 11.1 pg 10−6 platelets) was significantly increased ( < 0.05, = 27). This stimulatory effect was achieved at low concentrations of riluzole (from 10 M) and was not observed when platelets were incubated with the drug for 24 h. The direct action of riluzole evoking BDNF release from human platelets at therapeutic concentrations is important and may contribute to the understanding of its mechanisms of action in the treatment of depression.application/pdfengBioMed Research International. New York. Vol. 2015 (2015), 6p., ID 189307Fator neurotrófico derivado do encéfaloRiluzolPlaquetasDepressãoRiluzole stimulates BDNF release from human plateletsEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT000968009.pdf.txt000968009.pdf.txtExtracted Texttext/plain33035http://www.lume.ufrgs.br/bitstream/10183/225834/2/000968009.pdf.txt4043e129ffd22503761be6c6e6b2c181MD52ORIGINAL000968009.pdfTexto completo (inglês)application/pdf1202405http://www.lume.ufrgs.br/bitstream/10183/225834/1/000968009.pdf075471a73bd478bd5b2810d8b2a444cbMD5110183/2258342021-08-18 05:20:18.273oai:www.lume.ufrgs.br:10183/225834Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-08-18T08:20:18Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Riluzole stimulates BDNF release from human platelets
title Riluzole stimulates BDNF release from human platelets
spellingShingle Riluzole stimulates BDNF release from human platelets
Turck, Patrick
Fator neurotrófico derivado do encéfalo
Riluzol
Plaquetas
Depressão
title_short Riluzole stimulates BDNF release from human platelets
title_full Riluzole stimulates BDNF release from human platelets
title_fullStr Riluzole stimulates BDNF release from human platelets
title_full_unstemmed Riluzole stimulates BDNF release from human platelets
title_sort Riluzole stimulates BDNF release from human platelets
author Turck, Patrick
author_facet Turck, Patrick
Frizzo, Marcos Emilio dos Santos
author_role author
author2 Frizzo, Marcos Emilio dos Santos
author2_role author
dc.contributor.author.fl_str_mv Turck, Patrick
Frizzo, Marcos Emilio dos Santos
dc.subject.por.fl_str_mv Fator neurotrófico derivado do encéfalo
Riluzol
Plaquetas
Depressão
topic Fator neurotrófico derivado do encéfalo
Riluzol
Plaquetas
Depressão
description Brain-derived neurotrophic factor (BDNF) has several functions in the central nervous system, where it contributes to brain development and its functionality through affecting neuronal survival and activity and also modulating neurotransmitter levels. This neurotrophin is also found in the serum, but its origin and peripheral function remain unknown. Although the source of circulating BDNF is uncertain, it is stored in platelets and can be released through pharmacological treatment. Decreased levels of BDNF in the serum have been related to the pathophysiology of depression, and this relationship is reinforced by the reversal of this condition by treatment with antidepressants. Recently, riluzole has been proposed for the treatment of depression because it has the ability to lower extracellular glutamate levels and increase BDNF expression; and both mechanisms could be associated with its antidepressant action. Considering that riluzole enhances BDNF levels in the serum of patients, we investigated if treatment with this drug could stimulate the release of this neurotrophin from human platelets obtained from healthy subjects. When platelets were incubated with riluzole for 4 h, the basal value of BDNF (92.9 ± 11.1 pg 10−6 platelets) was significantly increased ( < 0.05, = 27). This stimulatory effect was achieved at low concentrations of riluzole (from 10 M) and was not observed when platelets were incubated with the drug for 24 h. The direct action of riluzole evoking BDNF release from human platelets at therapeutic concentrations is important and may contribute to the understanding of its mechanisms of action in the treatment of depression.
publishDate 2015
dc.date.issued.fl_str_mv 2015
dc.date.accessioned.fl_str_mv 2021-08-18T04:39:24Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/225834
dc.identifier.issn.pt_BR.fl_str_mv 2314-6133
dc.identifier.nrb.pt_BR.fl_str_mv 000968009
identifier_str_mv 2314-6133
000968009
url http://hdl.handle.net/10183/225834
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv BioMed Research International. New York. Vol. 2015 (2015), 6p., ID 189307
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/225834/2/000968009.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/225834/1/000968009.pdf
bitstream.checksum.fl_str_mv 4043e129ffd22503761be6c6e6b2c181
075471a73bd478bd5b2810d8b2a444cb
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447762792087552